iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
75 hedge funds and large institutions have $46.1M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
20
Reduced
22
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$3.53M |
| 2 |
2
Jane Street
New York
|
$1.28M |
| 3 |
3
Nomura Asset Management
Tokyo,
Japan
|
$2.33K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
KAS
5
Kestra Advisory Services
Austin,
Texas
|
$501K |
